Sarah's lifesaving legacy of hope for cancer fighters

Vital study in her name to focus on preventing disease

- BY PAUL BRITTON

HUNDREDS of young women with and without breast cancer are being recruited to a pioneering new study created in the name of Girls Aloud singer Sarah Harding.

The Christie cancer centre in Manchester has announced the launch of the second phase of a research programme in memory of the late pop star from Stockport.

Sarah died from breast cancer at the age of 39 in September, 2021.

A fundraiser was set up in her name after her death supporting crucial work in the fight against the disease.

Since its inception three years ago, the Sarah Harding Breast Cancer Appeal has helped raise money for The Christie NHS Foundation Trust alongside Cancer Research UK and researchers at a number of universities.

A senior research fellow - Dr Hannah Harrison, from Burnage - has now been appointed as part of the study as the ‘Sarah Harding Young Women’s Breast Cancer Fellow.

Her work will focus solely on preventing breast cancer in young women.

The Christie has now released new details on the study’s aims and ideals. Dr Harrison will be based in The Manchester Breast Centre (MBC) and will lead her own team focusing on young women’s breast cancer.

She has studied breast cancer for more than 20 years.